These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7769203)

  • 1. Possible nizatidine-induced subfulminant hepatic failure.
    Chey WD; Kochman ML; Traber PG; Appelman HD; Gumucio JJ
    J Clin Gastroenterol; 1995 Mar; 20(2):164-7. PubMed ID: 7769203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal hepatic failure due to prolonged amiodarone treatment.
    Snir Y; Pick N; Riesenberg K; Yanai-Inbar I; Zirkin H; Schlaeffer F
    J Clin Gastroenterol; 1995 Apr; 20(3):265-6. PubMed ID: 7797846
    [No Abstract]   [Full Text] [Related]  

  • 3. End-stage liver disease developing with the use of methotrexate in heterozygous alpha 1-antitrypsin deficiency.
    Hilsden RJ; Urbanski SJ; Swain MG
    Arthritis Rheum; 1995 Jul; 38(7):1014-8. PubMed ID: 7612033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group.
    Cloud ML; Enas N; Offen WW
    Clin Pharmacol Ther; 1992 Sep; 52(3):307-13. PubMed ID: 1526089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nizatidine in the treatment of acute gastric ulcer: a multicenter trial.
    D'Angelo A
    Ital J Gastroenterol; 1994; 26(1 Suppl 1):16-8. PubMed ID: 8018979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autumn meeting of Interdisciplinary Group for Ulcer Study (G.I.S.U.) on the use of nizatidine in gastric ulcer. Firenze, 17 October 1992. Introduction.
    Di Mario F; Saggioro A
    Ital J Gastroenterol; 1994; 26(1 Suppl 1):1-2. PubMed ID: 8018977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nizatidine: a meta-analytical study].
    di Ciommo V; Ferrario F
    Clin Ter; 1993 Sep; 143(3):201-7. PubMed ID: 8222550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nizatidine].
    Romero M; Franzosi MG
    Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern trends in the treatment of ulcer disease (clinical study of nizatidine "Galitidine")].
    Dzambas D; Zivanović M; Majoros J; Petrović Z; Barjaktarović M; Hadnadev L; Tomić Z; Mrda Z; Damjanov D
    Med Pregl; 1992; 45(9-10):353-8. PubMed ID: 1344473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Price AH; Brogden RN
    Drugs; 1988 Nov; 36(5):521-39. PubMed ID: 2905640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudocirrhosis and liver failure in patients with metastatic breast cancer after treatment with palbociclib.
    Vuppalanchi R; Saxena R; Storniolo AMV; Chalasani N
    Hepatology; 2017 May; 65(5):1762-1764. PubMed ID: 27397671
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors of relapse in gastric ulcer: a one-year, double-blind, comparative study of nizatidine versus placebo.
    Battaglia G
    Ital J Gastroenterol; 1994; 26(1 Suppl 1):19-22. PubMed ID: 8018980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
    Levine LR; Cloud ML; Enas NH
    Arch Intern Med; 1993 Nov; 153(21):2449-54. PubMed ID: 8215749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of acute stomach ulcer with H2 receptor antagonists. A direct therapy comparison with 300 mg nizatidine nightly and 2 times 150 mg nizatidine with twice daily 150 mg ranitidine].
    Arnold R; Beckenbach P; Bock H; Bormann R; Brunner G; Daake H; Dammann HG; Dietrich K; Fuerer M; Geiter B
    Fortschr Med; 1989 Jun; 107(17):390-4. PubMed ID: 2568327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient.
    Nakano T; Kuroiwa T; Tsumita Y; Kaneko Y; Hiromura K; Ueki K; Nojima Y
    Clin Exp Nephrol; 2004 Jun; 8(2):160-2. PubMed ID: 15235935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nizatidine and acid-pepsin related gastrointestinal disease.
    Piper DW; Stiel D
    J Gastroenterol Hepatol; 1995; 10(2):205-7. PubMed ID: 7787168
    [No Abstract]   [Full Text] [Related]  

  • 17. [Manganese, hepatic failure and discoloration of laundry].
    Laursen E; Grandjean P
    Ugeskr Laeger; 1996 Jan; 158(4):434-5. PubMed ID: 8638307
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of 150 mg nizatidine BID or 300 mg at bedtime, and 150 mg ranitidine BID in the treatment of gastric ulcer--an 8-week randomized, double-blind multicentre study.
    Di Mario F; Battaglia G; Naccarato R; D'Angelo A; Saggioro A; Da Broi GL; Vezzadini P; Bianchi Porro G
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():62-5. PubMed ID: 1982108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and characterization of floating microballoons of nizatidine for effective treatment of gastric ulcers in murine model.
    Jain A; Pandey V; Ganeshpurkar A; Dubey N; Bansal D
    Drug Deliv; 2015 May; 22(3):306-11. PubMed ID: 24601855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
    Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G
    Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.